Geneos Wealth Management’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,550
| Closed | -$24.2K | – | 3131 |
|
|
2024
Q4 | $24.2K | Sell |
29,550
-4,300
| -13% | -$3.53K | ﹤0.01% | 1629 |
|
|
2024
Q3 | $27.8K | Hold |
33,850
| – | – | ﹤0.01% | 1426 |
|
|
2024
Q2 | $27.8K | Hold |
33,850
| – | – | ﹤0.01% | 1251 |
|
|
2024
Q1 | $27.4K | Hold |
33,850
| – | – | ﹤0.01% | 1265 |
|
|
2023
Q4 | $47.7K | Hold |
33,850
| – | – | ﹤0.01% | 1079 |
|
|
2023
Q3 | $39.6K | Hold |
33,850
| – | – | ﹤0.01% | 1144 |
|
|
2023
Q2 | $47.1K | Hold |
33,850
| – | – | ﹤0.01% | 1097 |
|
|
2023
Q1 | $47.4K | Hold |
33,850
| – | – | ﹤0.01% | 1098 |
|
|
2022
Q4 | $46K | Sell |
33,850
-7,000
| -17% | -$9.52K | ﹤0.01% | 1086 |
|
|
2022
Q3 | $62K | Sell |
40,850
-1,600
| -4% | -$2.43K | ﹤0.01% | 956 |
|
|
2022
Q2 | $98K | Sell |
42,450
-20,000
| -32% | -$46.2K | ﹤0.01% | 1015 |
|
|
2022
Q1 | $209K | Buy |
+62,450
| New | +$209K | 0.01% | 788 |
|